A vaccine designed to prevent breast cancer is moving into the next phase of study. Cleveland Clinic researchers will soon begin enrolling for phase 1-B. Researchers expect to have results from this early phase of research by the end of 2023.
A vaccine designed to prevent breast cancer is moving into the next phase of study. Cleveland Clinic researchers will soon begin enrolling for phase 1-B. Researchers expect to have results from this early phase of research by the end of 2023.
© 2024, KPVM-TV Channel 25
All material found on www.kpvm.tv is copyrighted.
No material may be reproduced or reused without explicit permission from KPVM-TV Channel 25.
KPVM-TV, Inc. is an equal opportunity employer. View EEO report here.
Built on Envisionwise Technology. Administrator Login
